NeuroSense Therapeutics Ltd. (NRSN)

NASDAQ: NRSN · IEX Real-Time Price · USD

1.330

+0.070 (5.56%)

At close: May 3, 2024, 4:00 PM

1.360

+0.030 (2.26%)

After-hours: May 3, 2024, 5:55 PM EDT

NeuroSense Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	23	10	14	26
Market Cap Growth	-	-29.61%	-47.52%	-
Enterprise Value	20	7	7	15
PE Ratio	-0.87	-0.87	-1.13	-6.55
PB Ratio	-5.22	-5.22	2.47	2.94
P/FCF Ratio	-1.15	-1.15	-1.82	-17.02
P/OCF Ratio	-1.16	-1.16	-1.83	-17.21
EV/EBITDA Ratio	-0.80	-0.80	-0.57	-5.41
EV/EBIT Ratio	-0.80	-0.80	-0.57	-5.40
EV/FCF Ratio	-0.85	-0.85	-0.91	-9.91
Debt / Equity Ratio	-0.04	-0.04	0.03	-
Debt / EBITDA Ratio	-0.01	-0.01	-0.01	-
Debt / FCF Ratio	-0.01	-0.01	-0.02	-
Quick Ratio	0.83	0.83	4.26	19.05
Current Ratio	0.84	0.84	4.28	19.12
Interest Coverage	-4.11	-4.11	-273.22	-2.41
Return on Equity (ROE)	6214.90%	6214.90%	-139.40%	-83.60%
Return on Assets (ROA)	-207.30%	-207.30%	-115.50%	-66.20%
Return on Capital (ROIC)	738.59%	738.59%	-235.03%	-62.04%
Earnings Yield	-48.93%	-115.29%	-88.77%	-15.25%
FCF Yield	-36.79%	-86.68%	-55.08%	-5.87%
Buyback Yield / Dilution	-8.34%	-8.34%	-84.27%	-13.12%
Total Shareholder Return	-8.34%	-8.34%	-84.27%	-13.12%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).